Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans

Infection and Immunity

Volumn 77, Issue 1, 2009, Pages 120-127

  Charlier, Caroline ^a   Nielsen, Kirsten ^b   Daou, Samira ^a   Brigitte, Madly ^c   Chretien, Fabrice ^c   Dromer, Françoise ^a,d  

^a CNRS   (France)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c INSERM   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BONE MARROW CELL; CELL FUNCTION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE SEVERITY; IN VITRO STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BRAIN; COLONY COUNT, MICROBIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; LEUKOCYTE REDUCTION PROCEDURES; LUNG; MALE; MENINGOENCEPHALITIS; MICE; MICE, INBRED BALB C; MONOCYTES; SPLEEN;

EID: 58449131342     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01065-08     Document Type: Article

References (57)

1. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725-1731.
2. Alvarez, M., and A. Casadevall. 2006. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 16:2161-2165.
3. Brandt, C. T., D. Holm, M. Liptrot, C. Ostergaard, J. D. Lundgren, N. Frimodt-Moller, I. C. Skovsted, and I. J. Rowland. 2008. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis. J. Infect. Dis. 197:235-244.
4. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans. American Society for Microbiology, Washington, DC.
5. Chang, Y. C., M. F. Stins, M. J. McCaffery, G. F. Miller, D. R. Pare, T. Dam, M. Paul-Satyaseela, K. S. Kim, and K. J. Kwon-Chung. 2004. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect. Immun. 72:4985-4995.
6. Charlier, C., F. Chretien, M. Baudrimont, E. Mordelet, O. Lortholary, and F. Dromer. 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am. J. Pathol. 166:421-432.
7. Charlier, C., F. Dromer, C. Leveque, L. Chartier, Y. S. Cordoliani, A. Fontanet, O. Launay, and O. Lortholary. 2008. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS ONE 3:e1950.
8. Chen, L. C., E. S. Blank, and A. Casadevall. 1996. Extracellular proteinase activity of Cryptococcus neoformans. Clin. Diagn. Lab. Immunol. 3:570-574.
9. Chen, S. H., M. F. Stins, S. H. Huang, Y. H. Chen, K. J. Kwon-Chung, Y. Chang, K. S. Kim, K. Suzuki, and A. Y. Jong. 2003. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J. Med. Microbiol. 52:961-970.
10. Chretien, F., O. Lortholary, I. Kansau, S. Neuville, F. Gray, and F. Dromer. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 186:522-530.
11. Coenjaerts, F. E., M. van der Flier, P. N. Mwinzi, A. E. Brouwer, J. Scharringa, W. S. Chaka, M. Aarts, A. Rajanuwong, D. A. van de Vijver, T. S. Harrison, and A. I. Hoepelman. 2004. Intrathecal production and secretion of vascular endothelial growth factor during cryptococcal meningitis. J. Infect. Dis. 190:1310-1317.
12. Del Maschio, A., A. De Luigi, I. Martin-Padura, M. Brockhaus, T. Bartfai, P. Fruscella, L. Adorini, G. Martino, R. Furlan, M. G. De Simoni, and E. Dejana. 1999. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 190:1351-1356.
13. Del Poeta, M. 2004. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot. Cell 3:1067-1075.
14. Diamond, R. D., and J. E. Bennett. 1973. Growth of Cryptococcus neoformans within human macrophages in vitro. Infect. Immun. 7:231-236.
15. Dromer, F., S. Mathoulin-Pelissier, O. Launay, and O. Lortholary. 2007. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D Study. PLoS Med. 4:e21.
16. Dromer, F., J. Salamero, A. Contrepois, C. Carbon, and P. Yeni. 1987. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55:742-748.
17. Eisenman, H. C., A. Casadevall, and E. E. McClelland. 2007. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Curr. Infect. Dis. Rep. 9:457-464.
18. Englen, M. D., Y. E. Valdez, N. M. Lehnert, and B. E. Lehnert. 1995. Granulocyte/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. J. Immunol. Methods 184:281-283.
19. European Economic Community Council Directive. 1986. On the approximation of laws, regulations and administrative provisions of the member states regarding the protection of animals used for experimental and other scientific purposes. J. Off. Commun. Eur. 1986:L358.
20. Harrison, T. S., and S. M. Levitz. 1997. Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus. J. Infect. Dis. 176:537-540.
21. Huffnagle, G. B., R. M. Strieter, T. J. Standiford, R. A. McDonald, M. D. Burdick, S. L. Kunkel, and G. B. Toews. 1995. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:4790-4797.
22. Jong, A., C. H. Wu, G. M. Shackleford, K. J. Kwon-Chung, Y. C. Chang, H. M. Chen, Y. Ouyang, and S. H. Huang. 2008. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell. Microbiol. 10:1313-1326.
23. Kawakami, K., Y. Koguchi, M. H. Qureshi, T. Zhang, Y. Kinjo, S. Yara, K. Uezu, K. Shibuya, S. Naoe, and A. Saito. 2002. Anti-CD11b monoclonal antibody suppresses brain dissemination of Cryptococcus neoformans in mice. Microbiol. Immunol. 46:181-186.
24. Kechichian, T. B., J. Shea, and M. Del Poeta. 2007. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect. Immun. 75:4792-4798.
25. Kierszenbaum, A. 2001. Histology and cell biology, 2nd ed., vol. 1. Elsevier Health Sciences, Amsterdam, The Netherlands.
26. Kim, K. S. 2003. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4:376-385.
27. Lee, S. C., D. W. Dickson, and A. Casadevall. 1996. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum. Pathol. 27:839-847.
28. Leenen, P. J., J. S. Voerman, K. Radosevic, N. van Rooijen, and W. van Ewijk. 1997. Mouse spleen dendritic cells. Phagocytic activity and expression of macrophage markers. Adv. Exp. Med. Biol. 417:91-95.
29. Levitz, S. M., S. H. Nong, K. F. Seetoo, T. S. Harrison, R. A. Speizer, and E. R. Simons. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885-890.
30. Levitz, S. M., E. A. North, Y. Jiang, S. H. Nong, H. Kornfeld, and T. S. Harrison. 1997. Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect. Immun. 65:903-908.
31. Lortholary, O., F. Dromer, S. Mathoulin-Pelissier, C. Fitting, L. Improvisi, J. M. Cavaillon, and B. Dupont. 2001. Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus. J. Infect. Dis. 183:294-302.
32. Lortholary, O., A. Fontanet, N. Memain, A. Martin, K. Sitbon, and F. Dromer. 2005. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19:1043-1049.
33. Lortholary, O., L. Improvisi, M. Nicolas, F. Provost, B. Dupont, and F. Dromer. 1999. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med. Mycol. 37:169-174.
34. Lortholary, O., G. Poizat, V. Zeller, S. Neuville, A. Boibieux, M. Alvarez, P. Dellamonica, F. Botterel, F. Dromer, and G. Chene. 2006. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 20:2183-2191.
35. Luberto, C., B. Martinez-Marino, D. Taraskiewicz, B. Bolanos, P. Chitano, D. L. Toffaletti, G. M. Cox, J. R. Perfect, Y. A. Hannun, E. Balish, and M. Del Poeta. 2003. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J. Clin. Investig. 112:1080-1094.
36. Ma, H., J. E. Croudace, D. A. Lammas, and R. C. May. 2007. Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol. 8:15.
37. Ma, H., J. E. Croudace, D. A. Lammas, and R. C. May. 2006. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 16:2156-2160.
38. Mandal, P., U. Banerjee, A. Casadevall, and J. D. Nosanchuk. 2005. Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India. J. Clin. Microbiol. 43:4766-4772.
39. Monari, C., F. Baldelli, D. Pietrella, C. Retini, C. Tascini, D. Francisci, F. Bistoni, and A. Vecchiarelli. 1997. Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans. J. Infect. 35:257-263.
40. Monga, D. P. 1981. Role of macrophages in resistance of mice to experimental cryptococcosis. Infect. Immun. 32:975-978.
41. Mozaffarian, N., A. Casadevall, and J. W. Berman. 2000. Inhibition of human endothelial cell chemokine production by the opportunistic fungal pathogen Cryptococcus neoformans. J. Immunol. 165:1541-1547.
42. Muller, W. A., and G. J. Randolph. 1999. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J. Leukoc. Biol. 66:698-704.
43. Nassif, X., S. Bourdoulous, E. Eugene, and P. O. Couraud. 2002. How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol. 10:227-232.
44. Nelson, R. T., J. Hua, B. Pryor, and J. K. Lodge. 2001. Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis. Genetics 157:935-947.
45. Nielsen, K., G. M. Cox, A. P. Litvintseva, E. Mylonakis, S. D. Malliaris, D. K. Benjamin, Jr., S. S. Giles, T. G. Mitchell, A. Casadevall, J. R. Perfect, and J. Heitman. 2005. Cryptococcus neoformans α strains preferentially disseminate to the central nervous system during coinfection. Infect. Immun. 73:4922-4933.
46. Nielsen, K., G. M. Cox, P. Wang, D. L. Toffaletti, J. R. Perfect, and J. Heitman. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and α isolates. Infect. Immun. 71:4831-4841.
47. Olszewski, M. A., M. C. Noverr, G. H. Chen, G. B. Toews, G. M. Cox, J. R. Perfect, and G. B. Huffnagle. 2004. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am. J. Pathol. 164:1761-1771.
48. Paterson, R. 2005. How West Nile virus crosses the blood-brain barrier. Lancet Neurol. 4:18.
49. Reijerkerk, A., G. Kooij, S. M. van der Pol, S. Khazen, C. D. Dijkstra, and H. E. de Vries. 2006. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 20:2550-2552.
50. Santangelo, R., H. Zoellner, T. Sorrell, C. Wilson, C. Donald, J. Djordjevic, Y. Shounan, and L. Wright. 2004. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect. Immun. 72:2229-2239.
51. Shea, J. M., T. B. Kechichian, C. Luberto, and M. Del Poeta. 2006. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect. Immun. 74:5977-5988.
52. Singh, N., O. Lortholary, B. D. Alexander, K. L. Gupta, G. T. John, K. Pursell, P. Munoz, G. B. Klintmalm, V. Stosor, R. del Busto, A. P. Limaye, J. Somani, M. Lyon, S. Houston, A. A. House, T. L. Pruett, S. Orloff, A. Humar, L. Dowdy, J. Garcia-Diaz, A. C. Kalil, R. A. Fisher, and S. Husain. 2005. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin. Infect. Dis. 40:1756-1761.
53. Sunderkotter, C., T. Nikolic, M. J. Dillon, N. Van Rooijen, M. Stehling, D. A. Drevets, and P. J. Leenen. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172:4410-4417.
54. Tucker, S. C., and A. Casadevall. 2002. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc. Natl. Acad. Sci. USA 99:3165-3170.
55. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174:83-93.
56. Walenkamp, A. M., W. S. Chaka, A. F. Verheul, V. V. Vaishnav, R. Cherniak, F. E. Coenjaerts, and I. M. Hoepelman. 1999. Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure. FEMS Immunol. Med. Microbiol. 26:309-318.
57. Wang, H., J. Sun, and H. Goldstein. 2008. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J. Virol. 82:7591-7600.